Clinical Trial Update: A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Zabedosertib (BAY1834845) to placebo in adults with moderate-to-severe atopic dermatitis. The study's results on efficacy and safety hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Zabedosertib (BAY1834845)

Snippet

Sponsor: Bayer | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-02-18